Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen sold 22,481 shares of the firm’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $68.77, for a total value of $1,546,018.37. Following the sale, the chief executive officer now directly owns 336,637 shares in the company, valued at approximately $23,150,526.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Shares of Agilent Technologies, Inc. (NYSE A) opened at $68.69 on Thursday. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $70.81. The company has a market capitalization of $22,499.00, a PE ratio of 29.50, a price-to-earnings-growth ratio of 2.76 and a beta of 1.27. The company has a quick ratio of 2.76, a current ratio of 3.30 and a debt-to-equity ratio of 0.37.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The firm had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the business posted $0.59 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. equities research analysts predict that Agilent Technologies, Inc. will post 2.57 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.87%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. The ex-dividend date of this dividend is Friday, December 29th. Agilent Technologies’s dividend payout ratio (DPR) is presently 25.24%.
COPYRIGHT VIOLATION WARNING: “Agilent Technologies, Inc. (A) CEO Sells $1,546,018.37 in Stock” was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://transcriptdaily.com/2017/11/23/agilent-technologies-inc-a-ceo-sells-1546018-37-in-stock.html.
Several large investors have recently made changes to their positions in the company. Steward Partners Investment Advisory LLC purchased a new position in shares of Agilent Technologies in the third quarter worth about $213,000. Public Employees Retirement System of Ohio raised its stake in shares of Agilent Technologies by 0.9% in the third quarter. Public Employees Retirement System of Ohio now owns 394,744 shares of the medical research company’s stock worth $25,343,000 after purchasing an additional 3,452 shares during the last quarter. Coastline Trust Co raised its stake in shares of Agilent Technologies by 20.1% in the third quarter. Coastline Trust Co now owns 10,280 shares of the medical research company’s stock worth $660,000 after purchasing an additional 1,720 shares during the last quarter. Hahn Capital Management LLC raised its stake in shares of Agilent Technologies by 1.0% in the third quarter. Hahn Capital Management LLC now owns 598,781 shares of the medical research company’s stock worth $38,442,000 after purchasing an additional 5,648 shares during the last quarter. Finally, Americafirst Capital Management LLC purchased a new position in shares of Agilent Technologies in the third quarter worth about $743,000.
A number of equities research analysts recently weighed in on A shares. Robert W. Baird reaffirmed a “buy” rating and set a $70.00 price objective on shares of Agilent Technologies in a research report on Friday, October 20th. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price objective on the stock in a research report on Tuesday, October 10th. Deutsche Bank AG set a $68.00 price objective on Agilent Technologies and gave the company a “buy” rating in a research report on Wednesday, August 16th. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a research report on Tuesday, November 14th. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Agilent Technologies currently has an average rating of “Buy” and an average target price of $68.20.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.